Sezary Syndrome

Displaying 1 - 5 of 5CSV
Goyal, A., O’Leary, D., Dabaja, B., Weng, W.-K., Zain, J., Cutler, C., Guitart, J., Kim, Y. H., Geskin, L. J., Hoppe, R. T., Wilson, L. D., Beaven, A. W., Horwitz, S., Allen, P. B., Barta, S. K., Bohjanen, K., Brammer, J. E., Carter, J. B., Comfere, N., … Foss, F. (2024). ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome. Transplantation and Cellular Therapy, 30(11), 1047–1060. https://doi.org/10.1016/j.jtct.2024.08.020
Publication Date
Vadivel, C. K., Willerslev-Olsen, A., Namini, M. R. J., Zeng, Z., Yan, L., Danielsen, M., Gluud, M., Pallesen, E. M. H., Wojewoda, K., Osmancevic, A., Hedebo, S., Chang, Y.-T., Lindahl, L. M., Koralov, S. B., Geskin, L. J., Bates, S. E., Iversen, L., Litman, T., Bech, R., … Buus, T. B. (2024). Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome. Blood, 143(15), 1496–1512. https://doi.org/10.1182/blood.2023021671
Publication Date
Olsen, E. A., Whittaker, S., Willemze, R., Pinter-Brown, L., Foss, F., Geskin, L., Schwartz, L., Horwitz, S., Guitart, J., Zic, J., Kim, Y. H., Wood, G. S., Duvic, M., Ai, W., Girardi, M., Gru, A., Guenova, E., Hodak, E., Hoppe, R., … Scarisbrick, J. (2022). Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood, 140(5), 419–437. https://doi.org/10.1182/blood.2021012057
Publication Date
Gaydosik, A. M., Stonesifer, C. J., Khaleel, A. E., Geskin, L. J., & Fuschiotti, P. (2022). Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas. Clinical Cancer Research, 28(12), 2610–2622. https://doi.org/10.1158/1078-0432.ccr-21-4437
Publication Date